Literature DB >> 11285667

Childhood blindness in the context of VISION 2020--the right to sight.

C Gilbert1, A Foster.   

Abstract

The major causes of blindness in children vary widely from region to region, being largely determined by socioeconomic development, and the availability of primary health care and eye care services. In high-income countries, lesions of the optic nerve and higher visual pathways predominate as the cause of blindness, while corneal scarring from measles, vitamin A deficiency, the use of harmful traditional eye remedies, and ophthalmia neonatorum are the major causes in low-income countries. Retinopathy of prematurity is an important cause in middle-income countries. Other significant causes in all countries are cataract, congenital abnormalities, and hereditary retinal dystrophies. It is estimated that, in almost half of the children who are blind today, the underlying cause could have been prevented, or the eye condition treated to preserve vision or restore sight. The control of blindness in children is a priority within the World Health Organization's VISION 2020 programme. Strategies need to be region specific, based on activities to prevent blindness in the community--through measles immunization, health education, and control of vitamin A deficiency--and the provision of tertiary-level eye care facilities for conditions that require specialist management.

Entities:  

Mesh:

Year:  2003        PMID: 11285667      PMCID: PMC2566382     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  305 in total

Review 1.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Causes of childhood blindness: results from schools for the blind in south eastern Nigeria.

Authors:  I R Ezegwui; R E Umeh; U F Ezepue
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation.

Authors:  Fengfu Li; David Carlsson; Chris Lohmann; Erik Suuronen; Sandy Vascotto; Karin Kobuch; Heather Sheardown; Rejean Munger; Masatsugu Nakamura; May Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

Review 4.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

5.  Causes of blindness at the "Wiyata Guna" School for the Blind, Indonesia.

Authors:  R Sitorus; M Preising; B Lorenz
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

6.  Childhood vision impairment.

Authors:  J Keeffe
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

7.  Preparation and physical properties of a novel biocompatible porcine corneal acellularized matrix.

Authors:  Yi Shao; Luowa Quyang; Yueping Zhou; Jing Tang; Yuehui Tan; Qiuping Liu; Zhirong Lin; Tingting Yin; Fangfang Qiu; Zuguo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-06-09       Impact factor: 2.416

8.  Changing spectrum of retinopathy of prematurity (ROP) and variations among siblings of multiple gestation.

Authors:  Vikrant Sood; Harish Chellani; Sugandha Arya; B P Guliani
Journal:  Indian J Pediatr       Date:  2011-10-15       Impact factor: 1.967

9.  Anterior lens capsule management in pediatric cataract surgery.

Authors:  M Edward Wilson
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders.

Authors:  Steven L Williams; Lu Wang; Steven A Kane; Thomas C Lee; David J Weissgold; Audina M Berrocal; Daniel Rabinowitz; Justin Starren; John T Flynn; Michael F Chiang
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.